Loading...

ALXO ALX ONCOLOGY HOLDINGS INC Delisting Actions 8-K Filing

LX N

LX

ALX ONCOLOGY HOLDINGS INC

(ALXO)

2025 8-K

Financial Results Report

Management Changes

Financial Statements

Notice of Delisting

Financial Results

Workforce Reduction

Management Changes

Equity Incentive Plan

Management Changes

Management Change

Earnings Reports

Appointment of Director and...

Annual Meeting of Stockholders

Earnings Reports

Resignation of Directors

Financial Results Announcement

Loan Agreement Amendment

Financial Results Announcement

Underwriting Agreement for ...

Earnings Reports

Study Protocol and Interim ...

Financial Results Announcement

Amended and Restated Bylaws

Earnings Reports

FDIC Receivership

Financial Results Announcement

External Links:

ALX Oncology Holdings Inc. received a notice on April 23, 2025, from Nasdaq that it has not met the minimum bid price requirement for continued listing, giving the company until October 20, 2025, to comply by having a stock price of at least $1.00 for 10 consecutive business days.

AI Assistant

ALX ONCOLOGY HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.